TY - JOUR
T1 - The compound action potential in subjects receiving a cochlear implant
AU - Scott, William C.
AU - Giardina, Christopher K.
AU - Pappa, Andrew K.
AU - Fontenot, Tatyana E.
AU - Anderson, Meredith L.
AU - Dillon, Margaret T.
AU - Brown, Kevin D.
AU - Pillsbury, Harold C.
AU - Adunka, Oliver F.
AU - Buchman, Craig A.
AU - Fitzpatrick, Douglas C.
N1 - Publisher Copyright:
© 2016, Otology & Neurotology, Inc.
PY - 2016/11/28
Y1 - 2016/11/28
N2 - Hypothesis: The compound action potential (CAP) is a purely neural component of the cochlea's response to sound, and may provide information regarding the existing neural substrate in cochlear implant (CI) subjects that can help account for variance in speech perception outcomes. Background: Measurement of the "total response" (TR), or sum of the magnitudes of spectral components in the ongoing responses to tone bursts across frequencies, has been shown to account for 40 to 50% of variance in speech perception outcomes. The ongoing response is composed of both hair cell and neural components. This correlation may be improved with the addition of the CAP. Methods: Intraoperative round window electrocochleography (ECochG) was performed in adult and pediatric CI subjects (n=238). Stimuli were tones of different frequencies (250 Hz-4 kHz) at 90 dB nHL. The CAP was assessed in two ways, as an amplitude and with a scaling factor derived from a function fitted to the response. The results were correlated with consonant-nucleus-consonant (CNC) word scores at 6 months post-implantation (n=51). Results: Only about half of the subjects had a measurable CAP at any frequency. The CNC word scores correlated weakly with both amplitude (r2=0.20, p<0.001) and scaling factor (r2=0.25, p<0.01). In contrast, the TR alone accounted for 43% of the variance, and addition of either CAP measurement in multiple regression did not account for additional variance. Conclusions: The underlying pathology in CI patients causes the CAP to be often absent and highly variable when present. The TR is a better predictor of speech perception outcomes than the CAP.
AB - Hypothesis: The compound action potential (CAP) is a purely neural component of the cochlea's response to sound, and may provide information regarding the existing neural substrate in cochlear implant (CI) subjects that can help account for variance in speech perception outcomes. Background: Measurement of the "total response" (TR), or sum of the magnitudes of spectral components in the ongoing responses to tone bursts across frequencies, has been shown to account for 40 to 50% of variance in speech perception outcomes. The ongoing response is composed of both hair cell and neural components. This correlation may be improved with the addition of the CAP. Methods: Intraoperative round window electrocochleography (ECochG) was performed in adult and pediatric CI subjects (n=238). Stimuli were tones of different frequencies (250 Hz-4 kHz) at 90 dB nHL. The CAP was assessed in two ways, as an amplitude and with a scaling factor derived from a function fitted to the response. The results were correlated with consonant-nucleus-consonant (CNC) word scores at 6 months post-implantation (n=51). Results: Only about half of the subjects had a measurable CAP at any frequency. The CNC word scores correlated weakly with both amplitude (r2=0.20, p<0.001) and scaling factor (r2=0.25, p<0.01). In contrast, the TR alone accounted for 43% of the variance, and addition of either CAP measurement in multiple regression did not account for additional variance. Conclusions: The underlying pathology in CI patients causes the CAP to be often absent and highly variable when present. The TR is a better predictor of speech perception outcomes than the CAP.
KW - Cochlear potentials
KW - ECochG
KW - Electrocochleography
KW - Intraoperative
KW - Round window.
UR - http://www.scopus.com/inward/record.url?scp=84991435160&partnerID=8YFLogxK
U2 - 10.1097/MAO.0000000000001224
DO - 10.1097/MAO.0000000000001224
M3 - Article
C2 - 27749750
AN - SCOPUS:84991435160
SN - 1531-7129
VL - 37
SP - 1654
EP - 1661
JO - Otology and Neurotology
JF - Otology and Neurotology
IS - 10
ER -